Ivermectin: facts and science are in its favour – Dr Rapiti

Loading player...
In August 2021, BizNews conducted a panel discussion with Professor Colleen Aldous, Dr Nathi Mdladla and Dr Pinky Ngcakani – all of whom are strongly in favour of ivermectin. The discussion was published on BizNews TV on YouTube and for a year, it managed to evade the YouTube censorship police. Last week, Results of a Prospective Observational Study of a Strictly Controlled Population of 88,012 Subjects showed that Regular Use of Ivermectin as Prophylaxis for COVID-19 led to a 92% Reduction in COVID-19 Mortality Rate in a Dose-Response Manner. First thing this morning, BizNews received notification of a strike on our BizNews TV YouTube channel on account of the ivermectin panel discussion, which was taken down. The timing appears too odd for coincidence. What may be more realistic is that the World Health Organisation, which is in close ‘cahoots’ with YouTube, is doing a sweep of all pro-ivermectin content. This is the original ivermectin panel discussion podcast. Learn more about your ad choices. Visit megaphone.fm/adchoices
5 Sep 2022 11AM English South Africa Investing · Business News

Other recent episodes

BNC#8 Piet Viljoen - Survive first, profit later: Why history beats prediction in investing

Piet dismantles the myth of market prediction, arguing that success comes from judgment, discipline, and respect for history. Drawing on timeless lessons, he reveals why human behaviour drives cycles, why diversification and liquidity matter, and why survival beats brilliance. In a world obsessed with forecasts, this approach focuses on resilience,…
20 Mar 5AM 27 min

BNC#8 truth over hype: Magnus on investing, independence, and winning in a tough economy

Magnus built his career on questioning narratives and pursuing truth - first in journalism, then in financial advice. From navigating market volatility to championing global investing, his journey reflects resilience and independence. In a challenging South African economy, his message is clear: think critically, stay global, and never compromise on…
19 Mar 8AM 23 min